MRFR分析によると、DNA修復薬の市場規模は2022年に7.34 (10億ドル) と推定されました. この市場は2023年の8.23 (10億ドル) から2032年までに23.1 (10億ドル) に成長し、予測期間 (2024-2032) のCAGRは約12.15% になると予想されます。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET, BY MECHANISM OF ACTION (USD BILLION)
6.1. PARP Inhibition
6.2. DNA Damage Response
6.3. Cell Cycle Checkpoint Regulation
7. DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET, BY ADMINISTRATION ROUTE (USD BILLION)
7.1. Oral
7.2. Intravenous
7.3. Subcutaneous
8. DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET, BY INDICATION (USD BILLION)
8.1. Breast Cancer
8.2. Ovarian Cancer
8.3. Prostate Cancer
8.4. Pancreatic Cancer
9. DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET, BY THERAPEUTIC AREA (USD BILLION)
9.1. Oncology
9.2. Hematology
9.3. Genetic Disorders
10. DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the DNA Repair Drug Focus on PARP Inhibitors Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the DNA Repair Drug Focus on PARP Inhibitors Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Bayer
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Merck
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Clovis Oncology
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. OncoOne
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Medivir
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Novartis
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. AstraZeneca
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. AbbVie
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Eisai
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. BristolMyers Squibb
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Celleron Therapeutics
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Roche
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Pfizer
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. GSK
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 7. US DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 8. US DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 9. US DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 10. US DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 11. US DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 18. EUROPE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 19. EUROPE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. GERMANY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 23. GERMANY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 24. GERMANY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 25. GERMANY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 27. UK DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 28. UK DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 29. UK DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 30. UK DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 31. UK DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. FRANCE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 33. FRANCE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 34. FRANCE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 35. FRANCE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 36. FRANCE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 37. RUSSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 38. RUSSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 39. RUSSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 40. RUSSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 41. RUSSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. ITALY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 43. ITALY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 44. ITALY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 45. ITALY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 46. ITALY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 47. SPAIN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 48. SPAIN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 49. SPAIN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 50. SPAIN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 51. SPAIN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 52. REST OF EUROPE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 53. REST OF EUROPE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 54. REST OF EUROPE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 55. REST OF EUROPE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 56. REST OF EUROPE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 57. APAC DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 58. APAC DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 59. APAC DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 60. APAC DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 61. APAC DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. CHINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 63. CHINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 64. CHINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 65. CHINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 66. CHINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 67. INDIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 68. INDIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 69. INDIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 70. INDIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 71. INDIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 72. JAPAN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 73. JAPAN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 74. JAPAN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 75. JAPAN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 76. JAPAN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 77. SOUTH KOREA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 78. SOUTH KOREA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 79. SOUTH KOREA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 80. SOUTH KOREA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 81. SOUTH KOREA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. MALAYSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 83. MALAYSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 84. MALAYSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 85. MALAYSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 86. MALAYSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 87. THAILAND DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 88. THAILAND DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 89. THAILAND DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 90. THAILAND DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 91. THAILAND DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. INDONESIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 93. INDONESIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 94. INDONESIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 95. INDONESIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 96. INDONESIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 97. REST OF APAC DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF APAC DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF APAC DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF APAC DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF APAC DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. SOUTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 103. SOUTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 104. SOUTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 105. SOUTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 106. SOUTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 107. BRAZIL DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 108. BRAZIL DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 109. BRAZIL DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 110. BRAZIL DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 111. BRAZIL DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 112. MEXICO DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 113. MEXICO DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 114. MEXICO DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 115. MEXICO DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 116. MEXICO DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 117. ARGENTINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 118. ARGENTINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 119. ARGENTINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 120. ARGENTINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 121. ARGENTINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 127. MEA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 128. MEA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 129. MEA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 130. MEA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 131. MEA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 132. GCC COUNTRIES DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 133. GCC COUNTRIES DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 134. GCC COUNTRIES DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 135. GCC COUNTRIES DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 136. GCC COUNTRIES DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 137. SOUTH AFRICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 138. SOUTH AFRICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 139. SOUTH AFRICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 140. SOUTH AFRICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 141. SOUTH AFRICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 142. REST OF MEA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY MECHANISM OF ACTION, 2019-2032 (USD BILLIONS)
TABLE 143. REST OF MEA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 144. REST OF MEA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 145. REST OF MEA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF MEA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS
FIGURE 3. US DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 4. US DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 5. US DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 6. US DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 7. US DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 9. CANADA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 10. CANADA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 11. CANADA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 12. CANADA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS
FIGURE 14. GERMANY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 15. GERMANY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 16. GERMANY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 17. GERMANY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 18. GERMANY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 20. UK DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 21. UK DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 22. UK DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 23. UK DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 25. FRANCE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 26. FRANCE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 27. FRANCE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 28. FRANCE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 30. RUSSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 31. RUSSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 32. RUSSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 33. RUSSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 35. ITALY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 36. ITALY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 37. ITALY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 38. ITALY DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 40. SPAIN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 41. SPAIN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 42. SPAIN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 43. SPAIN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 45. REST OF EUROPE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 46. REST OF EUROPE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 47. REST OF EUROPE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 48. REST OF EUROPE DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS
FIGURE 50. CHINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 51. CHINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 52. CHINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 53. CHINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 54. CHINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 56. INDIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 57. INDIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 58. INDIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 59. INDIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 61. JAPAN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 62. JAPAN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 63. JAPAN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 64. JAPAN DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 66. SOUTH KOREA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 67. SOUTH KOREA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 68. SOUTH KOREA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 69. SOUTH KOREA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 71. MALAYSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 72. MALAYSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 73. MALAYSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 74. MALAYSIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 76. THAILAND DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 77. THAILAND DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 78. THAILAND DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 79. THAILAND DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 81. INDONESIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 82. INDONESIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 83. INDONESIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 84. INDONESIA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 86. REST OF APAC DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 87. REST OF APAC DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 88. REST OF APAC DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 89. REST OF APAC DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS
FIGURE 91. BRAZIL DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 92. BRAZIL DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 93. BRAZIL DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 94. BRAZIL DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 95. BRAZIL DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 97. MEXICO DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 98. MEXICO DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 99. MEXICO DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 100. MEXICO DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 102. ARGENTINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 103. ARGENTINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 104. ARGENTINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 105. ARGENTINA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 107. REST OF SOUTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 108. REST OF SOUTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 109. REST OF SOUTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 110. REST OF SOUTH AMERICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 113. GCC COUNTRIES DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 114. GCC COUNTRIES DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 115. GCC COUNTRIES DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 116. GCC COUNTRIES DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 118. SOUTH AFRICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 119. SOUTH AFRICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 120. SOUTH AFRICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 121. SOUTH AFRICA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY MECHANISM OF ACTION
FIGURE 123. REST OF MEA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 124. REST OF MEA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY INDICATION
FIGURE 125. REST OF MEA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 126. REST OF MEA DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET
FIGURE 133. DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET, BY MECHANISM OF ACTION, 2024 (% SHARE)
FIGURE 134. DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET, BY MECHANISM OF ACTION, 2019 TO 2032 (USD Billions)
FIGURE 135. DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET, BY ADMINISTRATION ROUTE, 2024 (% SHARE)
FIGURE 136. DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET, BY ADMINISTRATION ROUTE, 2019 TO 2032 (USD Billions)
FIGURE 137. DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET, BY INDICATION, 2024 (% SHARE)
FIGURE 138. DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET, BY INDICATION, 2019 TO 2032 (USD Billions)
FIGURE 139. DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET, BY THERAPEUTIC AREA, 2024 (% SHARE)
FIGURE 140. DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET, BY THERAPEUTIC AREA, 2019 TO 2032 (USD Billions)
FIGURE 141. DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. DNA REPAIR DRUG FOCUS ON PARP INHIBITORS MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
